Ratios Uncovered: Breaking Down Surgery Partners Inc (SGRY)’s Trailing Twelve Months Metrics

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Surgery Partners Inc (NASDAQ: SGRY) closed at $21.03 in the last session, down -2.64% from day before closing price of $21.60. In other words, the price has decreased by -$2.64 from its previous closing price. On the day, 1.38 million shares were traded. SGRY stock price reached its highest trading level at $21.88 during the session, while it also had its lowest trading level at $20.82.

Ratios:

We take a closer look at SGRY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.36. For the most recent quarter (mrq), Quick Ratio is recorded 1.66 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 1.86 whereas as Long-Term Debt/Eq ratio is at 1.78.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on December 16, 2024, initiated with a Buy rating and assigned the stock a target price of $30.

On October 14, 2024, UBS started tracking the stock assigning a Buy rating and target price of $38.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 05 ’24 when Bradley Owens bought 9,241 shares for $30.69 per share.

Bane Harrison R. sold 6,325 shares of SGRY for $196,742 on Sep 04 ’24. The National Group President now owns 48,236 shares after completing the transaction at $31.11 per share. On Sep 04 ’24, another insider, Harrison Bane, who serves as the Officer of the company, bought 6,325 shares for $31.11 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGRY now has a Market Capitalization of 2673207552 and an Enterprise Value of 7592427520. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.90 while its Price-to-Book (P/B) ratio in mrq is 1.41. Its current Enterprise Value per Revenue stands at 2.543 whereas that against EBITDA is 12.741.

Stock Price History:

Over the past 52 weeks, SGRY has reached a high of $35.29, while it has fallen to a 52-week low of $19.90. The 50-Day Moving Average of the stock is -21.27%, while the 200-Day Moving Average is calculated to be -23.83%.

Shares Statistics:

According to the various share statistics, SGRY traded on average about 1.02M shares per day over the past 3-months and 1435670 shares per day over the past 10 days. A total of 127.13M shares are outstanding, with a floating share count of 73.97M. Insiders hold about 41.80% of the company’s shares, while institutions hold 68.04% stake in the company. Shares short for SGRY as of 1732838400 were 11193553 with a Short Ratio of 11.00, compared to 1730332800 on 10160025. Therefore, it implies a Short% of Shares Outstanding of 11193553 and a Short% of Float of 19.379999.

Most Popular